Published in J Exp Med on August 07, 2000
Formins regulate the actin-related protein 2/3 complex-independent polarization of the centrosome to the immunological synapse. Immunity (2007) 3.14
HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. Immunity (2006) 2.23
Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J Exp Med (2004) 1.39
Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line. EMBO J (2002) 1.28
Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms. J Exp Med (2001) 1.23
WASH knockout T cells demonstrate defective receptor trafficking, proliferation, and effector function. Mol Cell Biol (2012) 1.10
Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes. EMBO J (2000) 1.08
RasGRF2, a guanosine nucleotide exchange factor for Ras GTPases, participates in T-cell signaling responses. Mol Cell Biol (2007) 1.07
The Gammaherpesvirus m2 protein manipulates the Fyn/Vav pathway through a multidocking mechanism of assembly. PLoS One (2008) 1.03
PIPKI gamma 90 negatively regulates LFA-1-mediated adhesion and activation in antigen-induced CD4+ T cells. J Immunol (2010) 0.92
Tyrosine-phosphorylated caveolin-1 blocks bacterial uptake by inducing Vav2-RhoA-mediated cytoskeletal rearrangements. PLoS Biol (2010) 0.91
Differential regulation of TCR-mediated gene transcription by Vav family members. J Exp Med (2004) 0.90
Dynamin 2 regulates granule exocytosis during NK cell-mediated cytotoxicity. J Immunol (2008) 0.87
Identification of the Eph receptor pathway as a novel target for eicosapentaenoic acid (EPA) modification of gene expression in human colon adenocarcinoma cells (HT-29). Nutr Metab (Lond) (2010) 0.78
The N-terminal 20-amino acid region of guanine nucleotide exchange factor Vav1 plays a distinguished role in T cell receptor-mediated calcium signaling. J Biol Chem (2012) 0.76
SH2 domains recognize specific phosphopeptide sequences. Cell (1993) 17.28
Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol (1994) 5.02
Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature (1992) 4.46
Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science (1998) 4.41
Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell (1999) 4.19
Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature (1997) 4.05
vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J (1989) 3.67
The Dbl family of oncogenes. Curr Opin Cell Biol (1996) 3.50
PH domains: diverse sequences with a common fold recruit signaling molecules to the cell surface. Cell (1996) 3.35
Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med (1997) 3.32
Regulatory and signaling properties of the Vav family. Mol Cell Biol (2000) 3.14
Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature (1992) 2.97
Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol (1981) 2.92
Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J (1998) 2.34
Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol Cell Biol (1999) 2.19
Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity (1996) 2.18
The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. Proc Natl Acad Sci U S A (1999) 1.98
Lck regulates Vav activation of members of the Rho family of GTPases. Mol Cell Biol (1997) 1.96
A functional T-cell receptor signaling pathway is required for p95vav activity. Mol Cell Biol (1995) 1.88
Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol (1991) 1.82
Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science (1992) 1.73
Rho is required for the initiation of calcium signaling and phagocytosis by Fcgamma receptors in macrophages. J Exp Med (1997) 1.71
Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes. Oncogene (1996) 1.62
Signal transduction in T lymphocytes using a conditional allele of Sos. Proc Natl Acad Sci U S A (1995) 1.61
Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene (1996) 1.57
Tyrosine phosphorylation provides an early and requisite signal for the activation of natural killer cell cytotoxic function. Proc Natl Acad Sci U S A (1991) 1.53
Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP. J Immunol (1988) 1.49
The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J Exp Med (1998) 1.43
The pleckstrin homology domain mediates transformation by oncogenic dbl through specific intracellular targeting. J Biol Chem (1996) 1.40
The GTPase Rho has a critical regulatory role in thymus development. EMBO J (1997) 1.32
Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J Exp Med (1994) 1.23
Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1. Ann Hum Genet (1995) 1.21
Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. J Immunol (1997) 1.20
Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J Exp Med (1997) 1.18
A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. Effects of herbimycin A. J Immunol (1992) 1.17
Distinct roles for DH and PH domains in the Lbc oncogene. Oncogene (1997) 1.16
Views on Vav. Immunol Today (1997) 1.15
Different functions of the GTPase Rho in prothymocytes and late pre-T cells. Immunity (1997) 1.14
ADP-ribosylation of the ras-related, GTP-binding protein RhoA inhibits lymphocyte-mediated cytotoxicity. J Biol Chem (1992) 1.12
Specific subdomains of Vav differentially affect T cell and NK cell activation. J Immunol (2000) 1.08
Vav links antigen-receptor signaling to the actin cytoskeleton. Semin Immunol (1998) 1.04
The small GTP-binding protein Rho potentiates AP-1 transcription in T cells. Mol Cell Biol (1998) 1.02
Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity. J Immunol (1999) 0.98
Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav. Oncogene (1993) 0.92
GTPases in antigen receptor signalling. Curr Opin Immunol (1998) 0.89
Lymphocyte signalling: a coordinating role for Vav? Curr Biol (1998) 0.88
Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase. Biochem J (1996) 0.84
Vav: Captain Hook for signal transduction? Crit Rev Oncog (1995) 0.81
Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc Natl Acad Sci U S A (2001) 6.22
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol (1996) 2.07
Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol Cell Biol (1998) 2.01
Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity (1996) 1.87
Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line. Mol Cell Biol (1992) 1.87
Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol (2000) 1.73
Fc gamma receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-gamma 1 and PLC-gamma 2 in natural killer cells. J Exp Med (1992) 1.55
Tyrosine phosphorylation provides an early and requisite signal for the activation of natural killer cell cytotoxic function. Proc Natl Acad Sci U S A (1991) 1.53
Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP. J Immunol (1988) 1.49
The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J Exp Med (1998) 1.43
A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. J Exp Med (2000) 1.39
Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol (1994) 1.27
Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I. Proc Natl Acad Sci U S A (1995) 1.25
Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J Exp Med (1994) 1.23
Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood (1997) 1.20
Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J Exp Med (1997) 1.18
Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J Immunol (1989) 1.16
Interaction between lck and syk family tyrosine kinases in Fc gamma receptor-initiated activation of natural killer cells. J Biol Chem (1995) 1.15
Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol (1996) 1.14
Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway. J Immunol (2000) 1.10
Diurnal variation in algal acetylene reduction (nitrogen fixation) in situ. Plant Physiol (1975) 1.10
Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. Proc Natl Acad Sci U S A (1992) 1.09
The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. J Clin Invest (1998) 1.09
MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. J Immunol (1993) 1.08
Specific subdomains of Vav differentially affect T cell and NK cell activation. J Immunol (2000) 1.08
Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes. EMBO J (2000) 1.08
SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J Biol Chem (1998) 1.06
Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J Immunol (1988) 1.03
Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J Immunol (1996) 1.02
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2. J Immunol (2001) 1.00
Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells. J Immunol (1990) 0.98
Clonal evolution of myeloma cells leads to quantitative changes in immunoglobulin secretion and surface antigen expression. Proc Natl Acad Sci U S A (1979) 0.97
IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J Immunol (1998) 0.96
Fc gamma receptor signal transduction in natural killer cells. Coupling to phospholipase C via a G protein-independent, but tyrosine kinase-dependent pathway. J Immunol (1991) 0.95
Cytokine-enhanced NK cell-mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis. J Immunol (1994) 0.95
Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int Immunol (1990) 0.94
A role for a RhoA/ROCK/LIM-kinase pathway in the regulation of cytotoxic lymphocytes. J Immunol (2001) 0.94
Inhibition of herpes simplex virus type 1 replication in fibroblast cultures by human blood mononuclear cells. J Virol (1986) 0.93
Cutting edge: a role for the adaptor protein LAT in human NK cell-mediated cytotoxicity. J Immunol (1999) 0.92
Signal transduction through the T-cell antigen receptor. Trends Biochem Sci (1992) 0.89
ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis. J Immunol (1997) 0.87
Alternative mechanisms of natural killer cell activation during herpes simplex virus infection. J Immunol (1990) 0.87
Regulation of p38 mitogen-activated protein kinase during NK cell activation. Eur J Immunol (2000) 0.86
Signal transduction through the T cell antigen receptor. Activation of phospholipase C through a G protein-independent coupling mechanism. J Immunol (1991) 0.85
Interaction between protein kinase C-dependent and G protein-dependent pathways in the regulation of natural killer cell granule exocytosis. J Biol Chem (1992) 0.84
Cutting edge: WIP, a binding partner for Wiskott-Aldrich syndrome protein, cooperates with Vav in the regulation of T cell activation. J Immunol (2000) 0.83
Time-dependent resistance or susceptibility of tumor cells to cytotoxic antibody after exposure to a chemotherapeutic agent. Proc Natl Acad Sci U S A (1978) 0.83
Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity. J Immunol (1989) 0.83
Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines. J Clin Immunol (1986) 0.83
The Fas pathway in apoptosis. Adv Pharmacol (1997) 0.81
Heritable and non-heritable variations in the phenotype of myeloma cells as detected by a fluorescence-activated cell sorter. J Histochem Cytochem (1979) 0.80
Heteroconjugate antibody-directed killing of autologous human renal carcinoma cells by in vitro-activated lymphocytes. J Immunol (1990) 0.80
Signal transduction by human NK cell MHC-recognizing receptors. Immunol Rev (1997) 0.79
Signal transduction during NK cell activation: balancing opposing forces. Curr Top Microbiol Immunol (1998) 0.79
Direct determination of the influence of the cell cycle on the survival of tumor cells exposed to cytotoxic antibodies. Cancer Res (1980) 0.79
Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis. Leuk Lymphoma (2001) 0.78
Changes in susceptibility to cytotoxic antibody among tumor cells surviving exposure to chemotherapeutic agents. Cancer Res (1982) 0.78
In vitro activation of lymphocytes from nonsmall cell cancer patients by interleukin 2 and anti-CD3 antibody. Clin Immunol Immunopathol (1989) 0.77
Demonstration of clonality, by X-linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophosphamide. Leukemia (1992) 0.77
Defective T-lymphocyte signal transduction and function in leukocyte adhesion deficiency. J Clin Immunol (1991) 0.76
Use of mutant Jurkat T cell lines to define human natural killer cell surface receptor signaling pathways. Methods Mol Biol (2000) 0.76
Nonrandom escape of tumor cells from immune lysis due to intraclonal fluctuations in antigen expression. Cancer Res (1983) 0.76
Signal transduction during NK cell activation. Chem Immunol (1996) 0.75
Signal transduction during natural killer cell activation. Curr Protoc Cytom (2001) 0.75
Interleukin-2 signal transduction in human NK cells: multisite phosphorylation and activation of the tyrosine kinase p56lck. J Leukoc Biol (1992) 0.75
Fc receptor stimulation of PI 3-kinase in NK cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. Ann N Y Acad Sci (1995) 0.75
Signal transduction during natural killer cell activation. Curr Protoc Immunol (2001) 0.75
Role for NK-cell-associated Fas ligand in cell-mediated cytotoxicity and apoptosis. Res Immunol (1997) 0.75
Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity in vivo. Int Immunol (1992) 0.75